AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Weekly Cannabis Sector Roundup: Trulieve Clears Debt, Curaleaf Delivers Solid Q3, Canopy Growth Slashes Losses, SNDL Reports Record Free Cash Flow, and Cronos Group Delivers Record Revenue and Profit Growth.
ByAinvest
Monday, Nov 10, 2025 9:55 am ET1min read
Trulieve Cannabis Corp. cleared $368M in debt early, reporting Q3 2025 revenue of $288M with 94% from retail sales and a 59% gross margin. Curaleaf delivered solid Q3 with rising cash flow and international momentum, while Canopy Growth slashed losses with cannabis sales surging in Q2 2026. SNDL reported record free cash flow and a 50% jump in cannabis operations revenue. Cronos Group delivered record revenue and strong profit growth in Q3 2025. Atai and Beckley Psytech completed a merger to form AtaiBeckley, and Compass Pathways reported Q3 2025 results as they accelerate the launch of COMP360 following FDA discussions.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet